- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Reckitt Benckiser Health India to sell Baddi facility to Hindustan Foods
The manufacturing facility is into manufacturing of vast variety of OTC health and wellness products and skin creams including some of Reckitt's key products.
Mumbai: Hindustan Foods Limited ("HFL") has executed Business Transfer Agreement (BTA) for acquisition of Reckitt Benckiser Health India Private Limited's manufacturing facility in Village Sandholi, Baddi, Himachal Pradesh ("Undertaking") as a move to further expand its Health Care & Wellness division.
Subject to fulfilment of the conditions precedent set out under BTA, the transfer of the Undertaking is expected to be completed by H2 of calendar year 2023. Upon completion, this acquisition will further enhance the company's offerings in the OTC Healthcare and Wellness segment.
The manufacturing facility is into manufacturing of vast variety of OTC health and wellness products and skin creams including some of Reckitt's key products. It is a state‐of‐the‐art facility with modern equipment and machinery and at par with global standards and adheres to the US FDA & MHRA, Russia GMP norms. All employees pertaining to the Sale Business as defined under BTA will be transferred to HFL as part of the acquisition with continuity of employment.
Upon Completion, HFL would manufacture various products for Reckitt and its affiliates in India and abroad. The acquisition also provides HFL an opportunity to leverage idle capacity for better utilization and incremental profits.
Sanjay Sehgal, President, Healthcare & Wellness Division, Hindustan Foods Limited said, "We are happy with this acquisition that enables us to further expand our offerings in the OTC Healthcare and Wellness segment, as a contract manufacturer. Baddi is India's prime pharma manufacturing hub and this facility provides HFL a cutting-edge manufacturing setup with multiple global and domestic certifications. Idle capacity can be deployed profitably to service new customers, and we are confident of scaling this business and delivering efficiently to our customers worldwide."
This project is the second acquisition under the OTC Healthcare and Wellness Segment. Earlier, HFL had acquired shares of entity having its manufacturing facility in Sriperumbudur, Tamil Nadu, and marked its entry in the OTC Healthcare and Wellness Segment.
Read also: Reckitt Benckiser: Laxman Narasimhan steps down as CEO, Nicandro Durante appointed
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751